SCHEMBL30468008

SCHEMBL30468008

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H]5CC[C@H](N6CCOCC6)CC5)c([N+](=O)[O-])c4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 7/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1701521 1.00 BCL2 (1.00) BCL2
SCHEMBL1701518 1.00 BCL2 (1.00) BCL2
SCHEMBL1958632 1.00 BCL2 (1.00) BCL2
SCHEMBL1807790 0.97 BCL2 (1.00) BCL2
SCHEMBL30467932 0.97 BCL2 (1.00) BCL2
SCHEMBL1956817 0.96 BCL2 (0.93) BCL2
SCHEMBL1957812 0.94 BCL2 (0.93) BCL2
SCHEMBL1957242 0.94 BCL2 (1.00) BCL2
SCHEMBL1957239 0.94 BCL2 (1.00) BCL2
SCHEMBL1701508 0.93 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4474383-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Ireland Unlimited Company (IE) 2024-12-11 — — EP disclosed
EP-4218731-A2 MELT-EXTRUDED SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT AbbVie Ireland Unlimited Company (IE) 2023-08-02 — — EP disclosed
Send feedback